Bone marrow-derived mesenchymal stem cells inhibit NK cell function via Tim-3/galectin-9 in multiple myeloma patients

Clin Transl Med. 2023 Mar;13(3):e1224. doi: 10.1002/ctm2.1224.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Marrow
  • Galectins
  • Hepatitis A Virus Cellular Receptor 2
  • Humans
  • Killer Cells, Natural
  • Mesenchymal Stem Cells*
  • Multiple Myeloma* / therapy

Substances

  • Hepatitis A Virus Cellular Receptor 2
  • Galectins